Although the risk of breast cancer for women in the U.S. is approximately 1 in 9, identification of risk factors and translation of that knowledge into strategies for prevention have been inhibited by poor understanding of disease pathogenesis. A few benign breast proliferations are associated with higher risk of breast cancer but definition of a preneoplastic morphologic continuum is lacking. The investigators propose to study 5353 eligible women, derived from a large multi-ethnic population, diagnosed by biopsy with benign breast disease between 1981-1991, followed from 5-15 years, and yielding an estimated 248 women who will have developed invasive breast cancer. The overall aims are to 1) ascertain the incidence and time span of breast cancer development in this cohort, 2) to estimate the frequency of selected genetic alterations in both benign breast disease (BBD) and invasive cancers from the same individuals in a subset of the cohort and 3) using a nested case-control approach, to evaluate risk factors for breast cancer among women with BBD, including specific histological characteristics, molecular markers, family history of breast cancer, and reproductive history. The purpose of the study is to evaluate the importance of biomarkers for risk for breast cancer development and determination of their contribution to definition of a genetic sequence in breast carcinogenesis. Assessment of genetic alterations will employ florescent in situ hybridization and the polymerase chain reaction (PCR). The PI will identify chromosomal aneuploidy, selective with respect to individual chromosomes and as a measure of DNA ploidy, and HER-2/neu amplification patterns in BBD and invasive cancer. The PI will identify p53 mutations by single strand conformation analysis (SSCP), determine clonality using the PCR nested primer approach for the PGK locus (on Xq arm), and assess loss of heterozygosity (LOH) for intragenic markers of the BRCA1 (17q21) and E-cadherin (16q22) genes. When LOH is observed, analysis of the genes using SSCP will attempt to identify the putative mutations. Lack of a constitutional BRCA1 mutation will rule out one form of inherited breast cancer, allowing subtyping of the remaining tumors by histopathological and genetic profiles, and time frame of cancer development. This study should help establish a genetic and morphologic continuum from BBD to breast cancer and provide a firmer basis for interpretation of the roles of known risk factors, with the eventual objective of permitting targeted testing of preventive strategies and therapeutic regimens.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
3R01CA070923-05S2
Application #
6495850
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Program Officer
Rosenfeld, Bobby
Project Start
1996-09-30
Project End
2004-09-29
Budget Start
2000-09-30
Budget End
2004-09-29
Support Year
5
Fiscal Year
2001
Total Cost
$113,828
Indirect Cost
Name
Henry Ford Health System
Department
Genetics
Type
Schools of Medicine
DUNS #
073134603
City
Detroit
State
MI
Country
United States
Zip Code
48202
Chen, Kang Mei; Stephen, Josena K; Raju, Usha et al. (2011) Delineating an epigenetic continuum for initiation, transformation and progression to breast cancer. Cancers (Basel) 3:1580-92
Worsham, Maria J; Raju, Usha; Lu, Mei et al. (2009) Risk factors for breast cancer from benign breast disease in a diverse population. Breast Cancer Res Treat 118:1-7
Worsham, Maria J; Abrams, Judith; Raju, Usha et al. (2007) Breast cancer incidence in a cohort of women with benign breast disease from a multiethnic, primary health care population. Breast J 13:115-21
Raju, Usha; Lu, Mei; Sethi, Seema et al. (2006) MOLECULAR CLASSIFICATION OF BREAST CARCINOMA IN SITU. Curr Genomics 7:523-532
Natarajan, Girija; Johnson, Yvette R; Zhang, Fan et al. (2006) Real-time polymerase chain reaction for the rapid detection of group B streptococcal colonization in neonates. Pediatrics 118:14-22
Worsham, Maria J; Pals, Gerard; Schouten, Jan P et al. (2003) Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 129:702-8
Barnabas, Nandita; Amin, Mitual B; Pindolia, Kirit et al. (2002) Mutations in the von Hippel-Lindau (VHL) gene refine differential diagnostic criteria in renal cell carcinoma. J Surg Oncol 80:52-60
Worsham, Maria J; Pals, Gerard; Raju, Usha et al. (2002) Establishing a molecular continuum in breast cancer DNA microarrays and benign breast disease. Cytometry 47:56-9
Worsham, M J; Wolman, S R; Zarbo, R J (2001) Molecular approaches to identification of tissue contamination in surgical pathology sections. J Mol Diagn 3:11-5
Barnabas, N; Shurafa, M; Van Dyke, D L et al. (2001) Significance of p53 mutations in patients with chronic lymphocytic leukemia: a sequential study of 30 patients. Cancer 91:285-93

Showing the most recent 10 out of 16 publications